13-Valent pneumococcal conjugate vaccine (PCV13) serotypes in adults with community acquired pneumonia in Taiwan

被引：0
|
作者：
Chang, S. C. [1 ]
Li, C. T. [2 ]
Cheng, S. L. [3 ]
Gray, S. [4 ]
Gonzalez, E. [4 ]
Pride, M. [4 ]
Sebastian, S. [4 ]
机构：
[1] Natl Taiwan Univ Hosp, Taipei, Taiwan
[2] Changhua Christian Hosp, Changhua, Changhua County, Taiwan
[3] Far Eastern Mem Hosp Taiwan, New Taipei City, Taiwan
[4] Pfizer Inc, Kalamazoo, MI USA
来源：
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2015年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
P2-EI27
引用
收藏
页码：S119 / S119
页数：1
相关论文
共 50 条
  • [1] 13-valent pneumococcal conjugate vaccine (PCV13)
    Jefferies, Johanna M. C.
    Macdonald, Emily
    Faust, Saul N.
    Clarke, Stuart C.
    [J]. HUMAN VACCINES, 2011, 7 (10): : 1012 - 1018
  • [2] Decrease of Pneumococcal Community-Acquired Pneumonia Hospitalization and Associated Complications in Children after the Implementation of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) in Taiwan
    Shen, Ching-Fen
    Chen, Ju-Ling
    Su, Chien-Chou
    Lin, Wen-Liang
    Hsieh, Min-Ling
    Liu, Ching-Chun
    Cheng, Ching-Lan
    [J]. VACCINES, 2021, 9 (09)
  • [3] A review of economic evaluations of 13-valent pneumococcal conjugate vaccine (PCV13) in adults and the elderly
    Dirmesropian, S.
    Wood, J. G.
    MacIntyre, C. R.
    Newall, A. T.
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2015, 11 (04) : 818 - 825
  • [4] 13-Valent Pneumococcal Conjugate Vaccine (PCV13) in Preterm Versus Term Infants
    Martinon-Torres, Federico
    Czajka, Hanna
    Center, Kimberly J.
    Wysocki, Jacek
    Majda-Stanislawska, Ewa
    Omenaca, Felix
    Bernaola Iturbe, Enrique
    Blazquez Gamero, Daniel
    Concheiro-Guisan, Ana
    Gimenez-Sanchez, Francisco
    Szenborn, Leszek
    Giardina, Peter C.
    Patterson, Scott
    Gruber, William C.
    Scott, Daniel A.
    Gurtman, Alejandra
    [J]. PEDIATRICS, 2015, 135 (04) : E876 - E886
  • [5] Impact of the 13-valent pneumococcal conjugate vaccine (pcv13) on invasive pneumococcal disease and carriage in Alaska
    Bruce, Michael G.
    Singleton, Rosalyn
    Bulkow, Lisa
    Rudolph, Karen
    Zulz, Tammy
    Gounder, Prabhu
    Hurlburt, Debby
    Bruden, Dana
    Hennessy, Thomas
    [J]. VACCINE, 2015, 33 (38) : 4813 - 4819
  • [6] One-step multiplex PCR for rapid identification of 13-valent pneumococcal conjugate vaccine (PCV13) serotypes
    Ari, Fatma Filiz
    Durmaz, Riza
    Guldemir, Dilek
    Otgun, Selin
    Acar, Bulent
    Ertek, Mustafa
    [J]. CURRENT OPINION IN BIOTECHNOLOGY, 2011, 22 : S108 - S109
  • [7] Cost-effectiveness of 13-valent pneumococcal conjugate vaccine (PCV13) in older Australians
    Dirmesropian, S.
    Wood, J. G.
    MacIntyre, C. R.
    Beutels, P.
    McIntyre, P.
    Menzies, R.
    Reyes, J. F.
    Chen, C.
    Newall, A. T.
    [J]. VACCINE, 2017, 35 (34) : 4307 - 4314
  • [8] Community-acquired pneumonia in the post 13-valent pneumococcal conjugate vaccine era
    Shaughnessy, Erin E.
    Stalets, Erika L.
    Shah, Samir S.
    [J]. CURRENT OPINION IN PEDIATRICS, 2016, 28 (06) : 786 - 793
  • [9] Cost-effectiveness of alternative strategies for use of 13-valent pneumococcal conjugate vaccine (PCV13) in Canadian adults
    Atwood, Mark
    Beausoleil, Linda
    Breton, Marie-Claude
    Laferriere, Craig
    Sato, Reiko
    Weycker, Derek
    [J]. CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE, 2018, 109 (5-6): : 756 - 768
  • [10] Cost-effectiveness of alternative strategies for use of 13-valent pneumococcal conjugate vaccine (PCV13) in Canadian adults
    Mark Atwood
    Linda Beausoleil
    Marie-Claude Breton
    Craig Laferriere
    Reiko Sato
    Derek Weycker
    [J]. Canadian Journal of Public Health, 2018, 109 : 756 - 768
12345